echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > China Chemical > The environmental protection pressure of the pharmaceutical industry continues to increase, what impact will it have on pharmaceutical companies?

    The environmental protection pressure of the pharmaceutical industry continues to increase, what impact will it have on pharmaceutical companies?

    • Last Update: 2021-06-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [ Focus on Chemical Machinery and Equipment Network ] Recently, the National Development and Reform Commission has issued the "Pollution Control, Energy Conservation and Carbon Reduction Special Investment Management Measures within the Central Budget" (Circular 655).
    Four directions: carbon, resource conservation and efficient use, and environmental pollution control.
    The industry believes that under the background of the country's vigorous promotion of green environmental protection and sustainable development, and the release of a series of policies, the pharmaceutical industry will face increasingly severe environmental pressures.
    Chemical machinery and equipment network hotspots pay attention to chemical machinery and equipment
    The pharmaceutical industry has always been a representative of high-polluting industries.
    According to the classification criteria, the pharmaceutical industry is divided into seven sub-sectors: chemical raw materials, chemical preparations, biological preparations, Chinese patent medicines, medical devices, sanitary materials, and Chinese herbal medicines.
    Among them, chemical raw materials and chemical preparations are the two largest sub-sectors.
    industry.
    The resulting air pollution, water pollution, solid waste pollution, noise pollution, etc.
    , are all having a lot of negative impacts on the environment, and at the same time restricting the sustainable development of the pharmaceutical industry.

    In recent years, the country's efforts to rectify the environmental protection of the pharmaceutical industry have been increasing.
    In this context, a large number of pharmaceutical companies have been required to restrict production or suspend production for rectification due to non-compliance with environmental protection standards.
    Statistics show that the number of environmental administrative penalties received by Chinese pharmaceutical companies during the ten years from 2011 to 2021 has soared.
    Although the number of penalties from 2018 to 2020 has declined, it is still higher than that of 2014-2016 and 2021.
    -The data for April is also significantly higher than the whole year of 2012.
    It can be seen that my country's pharmaceutical companies are still in a high-pressure situation of environmental protection.  

      The industry believes that under the background of my country's promotion of green development and sustainable development, pharmaceutical companies can only achieve better development if they attach great importance to the severe practical problems of pharmaceutical environmental protection and take action.
    But the treatment of pollution in the pharmaceutical industry has never been a simple matter.
    How should relevant companies act? It is reported that in order to better meet the discharge requirements of pharmaceutical wastewater, many companies have begun to take effective treatment and preventive measures for wastewater, waste gas, and waste residues generated in the pharmaceutical process.  

      For example, a pharmaceutical company has already invested more than 20 million yuan to build a solid waste incineration energy project by itself.
    It is understood that the project is divided into processes such as feeding, secondary incineration, waste heat utilization, quenching and neutralization, and multi-stage dust removal.
    The equipment has a high degree of automation, and the treated flue gas fully meets the relevant national emission standards.
    In addition, there are also pharmaceutical companies that use intelligent systems to effectively manage the use of energy resources, and insist on embarking on the path of green and high-quality development.
    It is reported that in the overall relocation, the company has invested a total of 1 billion yuan in the construction of environmental protection projects, and the application of multiple environmental protection technologies and the construction of environmental protection devices have been at the forefront of the industry.  

      It is worth noting that in addition to the direct construction of environmental protection treatment systems, the choice of more energy-saving and environmentally friendly pharmaceutical equipment has also become an important choice for more and more pharmaceutical companies to deal with environmental protection.
    Affected by this, many domestic pharmaceutical equipment companies have begun to pay close attention to environmental protection, innovating, upgrading and improving their equipment.
    It is understood that many companies have achieved dazzling results and are favored by pharmaceutical companies.  

      For example, a company has developed a new combined multi-effect distilled water machine that can provide sterile pharmaceuticals, injections, large infusions, and biopharmaceuticals for the pharmaceutical industry.
    It is reported that this equipment can operate continuously for 240 days, saving 65% comprehensive energy in terms of water saving, industrial steam saving, and reduction of enterprise sewage pressure.
    In addition, the technology used by the machine can save 21 million tons of standard coal and 340 million tons of drinking water every year.  

      In addition, the situation of exhaust gas emissions in the pharmaceutical industry is very complicated.
    There are also companies that have developed some specialized solutions for the characteristics of each customer's emissions.
    For example, for exhaust gas of different complexity, we will find out its emission composition and emission characteristics, and then formulate a reasonable treatment process.
    According to reports, the treatment process can be divided into pre-treatment, core process and post-treatment.
    In the pre-treatment section, some chemical washing and some water washing will be done to remove the acid and alkali components in the exhaust gas; in the core process section, the combustion method will be considered to destroy and decompose the exhaust gas to achieve Emission standards; and the post-processing is to ensure that the products after combustion can be effectively processed and more in line with the standards.  

      At present, from the national level to the local level, a series of policies and regulations are being promulgated to deal with the pollution problems caused by pharmaceuticals.
    It can be seen that in the future, the country's pollution control requirements for the pharmaceutical industry are expected to become stricter.
    In this context, the industry believes that pharmaceutical companies need diversified methods of pollution control.
    Under this demand, pharmaceutical equipment companies may also usher in more development opportunities.
    However, it is worth noting that in the actual application process, there are still a few pharmaceutical equipment that can truly achieve environmentally friendly production and "zero pollution" emissions, and most pharmaceutical equipment still has problems such as "poor equipment stability" and "short life".  
    Pharmaceutical equipment
      Therefore, the author believes that pharmaceutical equipment companies still need to combine the actual needs of pharmaceutical companies in many aspects, and through policy guidance and incentive support to strengthen product updates and improvements, in order to better contribute to the company and the entire industry.

     

      Original title: The environmental pressure of the pharmaceutical industry continues to increase, what impact will it have on pharmaceutical companies
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.